Survodutide
Survodutide
$ 250
A dual glucagon/GLP-1 receptor agonist currently in Phase 3 trials. The glucagon component amplifies energy expenditure and liver fat reduction, while GLP-1 handles appetite and insulin effects. Positioned for both obesity and MASH (metabolic fatty liver disease).
Benefits
✓ Significant weight reduction (15–20% in Phase 2)
✓ Potent liver fat reduction (MASH treatment)
✓ Increased energy expenditure
✓ Improved metabolic markers
✓ Dual-pathway synergy for greater fat burning
✓ Potent liver fat reduction (MASH treatment)
✓ Increased energy expenditure
✓ Improved metabolic markers
✓ Dual-pathway synergy for greater fat burning
Side Effects
• Nausea, vomiting, diarrhea (similar to GLP-1s)
• Decreased appetite
• Injection site reactions
• Potential hypoglycemia
• Fatigue during escalation
• Decreased appetite
• Injection site reactions
• Potential hypoglycemia
• Fatigue during escalation
Half Life
5–6 days
Note
FOR LABORATORY / RESEARCH USE ONLY. Not for human use or consumption. Not for animal or veterinary use or testing. Not a drug, food, cosmetic, or medical device, and not evaluated or approved by the FDA. Composition and dosing ratios are vendor-defined and not independently verified.
Survodutide
$ 250
A dual glucagon/GLP-1 receptor agonist currently in Phase 3 trials. The glucagon component amplifies energy expenditure and liver fat reduction, while GLP-1 handles appetite and insulin effects. Positioned for both obesity and MASH (metabolic fatty liver disease).
FOR LABORATORY / RESEARCH USE ONLY. Not for human use or consumption. Not for animal or veterinary use or testing. Not a drug, food, cosmetic, or medical device, and not evaluated or approved by the FDA. Composition and dosing ratios are vendor-defined and not independently verified.
✓ Significant weight reduction (15–20% in Phase 2)
✓ Potent liver fat reduction (MASH treatment)
✓ Increased energy expenditure
✓ Improved metabolic markers
✓ Dual-pathway synergy for greater fat burning
✓ Potent liver fat reduction (MASH treatment)
✓ Increased energy expenditure
✓ Improved metabolic markers
✓ Dual-pathway synergy for greater fat burning
5–6 days
Related Products
